arrow
J

José Luís Piñana

biomedical research institute
H指数:33
被引数:4,159

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1—viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT

造血干细胞移植和CAR T细胞治疗后中枢神经系统感染并发症的综合征导向性研究,第一部分——病毒性脑炎、脑膜炎和脊髓炎:来自EBMT实践协调与指南委员会的建议

2026-11-050
OA
Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy

供者NKG2A/NKG2C免疫表型影响NK细胞用于过继免疫治疗的GMP合规制备潜力

Cancers
IF4.4
2026-08-280
OA
Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).

异基因HSCT后成人患者发生SOS/VOD的发病率、临床危险因素及生物标志物。西班牙HSCT与细胞治疗工作组(GETH-TC)的真实世界研究。

2026-07-170
PRE
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging

异基因造血细胞移植后的中枢神经系统并发症:EBMT实践协调和指南委员会关于流行病学、结局和神经影像学的最佳实践建议

2026-05-130
PRE
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee

症状指导方法在异基因造血细胞移植受者中枢神经系统并发症中的应用:EBMT实践协调和指南委员会的最佳实践建议

2026-05-070
PRE
Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study

供体和受者EBV血清状态对异基因造血细胞移植后环磷酰胺治疗的急性白血病患者移植结局的影响:EBMT感染性疾病工作组回顾性研究

2026-05-040
PRE
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT

异基因造血细胞移植后出血性膀胱炎的发病率和结局:EBMT传染病工作组的一项调查

2026-03-260
PRE
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TC

通过机器学习方法揭示异基因干细胞移植后CMV风险特征:一项来自GETH-TC的多中心分析

2026-03-130
PRE
Corrigendum to ‘American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients’ [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016]

勘误:‘American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients’ [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016]

2025-11-190
PRE
Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma

阿基仑赛注射液治疗后侵袭性B细胞淋巴瘤的免疫重建模式

2025-10-050
OAAI
Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia

血液系统恶性肿瘤患者或造血细胞移植受者中的社区获得性呼吸道病毒感染:第10届欧洲白血病感染会议更新建议

2025-08-270
OAAI
Author’s Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

作者对来函的回复:ECIL-10关于COVID-19的指南应适当考虑康复血浆的应用(Focosi等人)

Leukemia
IF13.4
2025-08-040
PRE
Defining Bloodstream and Central Venous Catheter-Related Infections in Patients Following Haematopoietic Cell Transplantation: Position Paper of the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines Committee

定义造血细胞移植后患者血液感染和中心静脉导管相关感染的诊断标准:EBMT感染性疾病工作组与实践协调及指南委员会立场文件

2025-07-210
PRE